Systemic diseases
At the moment, systemic diseases are considered difficult to treat and treatment is mainly aimed at controlling the disease and slowing the progression of the pathological process.
According to the predominantly affected system of the body, the following are distinguished:
- systemic connective tissue diseases (scleroderma, systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, dermatopolymyositis, etc.)
- systemic diseases of the endocrine system (type 1 diabetes mellitus, Hashimoto's thyroiditis, diffuse toxic goiter, etc.)
- systemic diseases of the gastrointestinal tract (NUC, autoimmune hepatitis, autoimmune pancreatitis, biliary cirrhosis, Sjogren's syndrome, etc.)
- systemic blood diseases (thrombocytopenic purpura, hemolytic anemia, neutropenia, etc.)
- systemic kidney diseases (renal vasculitis, glomerulonephritis, glomerulopathy, etc.)
- systemic skin diseases (vitiligo, psoriasis, idiopathic dermatitis, vasculitis, autoimmune urticaria, alopecia, etc.)
- systemic diseases of the nervous system (myasthenia gravis, Guillain-Baré syndrome, etc.), etc.
All systemic autoimmune diseases are characterized by a chronic course with constant progression through gradual negative dynamics or according to the “exacerbation-remission” principle.
In treatment, the best results are shown by methods of traditional Chinese medicine in combination with innovative hardware treatment; methods of integrative medicine are used according to indications.
Each clinical case is individual and treatment is prescribed individually by highly qualified doctors after appropriate diagnosis.